Institut Biophytis SAS announced the nomination of Philippe Dupont as Chief Operating Officer in order to better support the company's expansion plans. More recently, he was the COO of Novagali Pharma (Santen group) where he managed the marketing of the medical devices and the Regulatory Affairs.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 EUR | 0.00% | +1.19% | -58.33% |
12:42pm | Biophytis unveils design for obesity study | CF |
1st Jan change | Capi. | |
---|---|---|
+4.35% | 111B | |
+10.94% | 105B | |
-12.16% | 22.34B | |
-3.90% | 21.93B | |
-5.99% | 18.59B | |
-36.52% | 18.12B | |
-9.94% | 16.96B | |
+3.40% | 13.7B | |
+36.45% | 12.45B |
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock
- News Biophytis S.A.
- Philippe Dupont Joined Biophytis as Chief Operating Officer